Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)
China
· Delayed Price · Currency is CNY 39.07
-0.22 (-0.56%)
Apr 29, 2026, 3:00 PM CST
SHA:603392 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -398.27 | 106.24 | 1,248 | 4,736 | 2,021 | Upgrade
|
| Depreciation & Amortization | 313.67 | 300.65 | 231.51 | 151.9 | 105.28 | Upgrade
|
| Other Amortization | 53.78 | 17.59 | 60.55 | 6.63 | 5.03 | Upgrade
|
| Loss (Gain) From Sale of Assets | -60.23 | -7.92 | -0.22 | -0.06 | 0.72 | Upgrade
|
| Asset Writedown & Restructuring Costs | 2.19 | 0.53 | 224.01 | 2.8 | 0.25 | Upgrade
|
| Loss (Gain) From Sale of Investments | -114.51 | -146.34 | -123.56 | -46.09 | -11.25 | Upgrade
|
| Provision & Write-off of Bad Debts | 23.08 | 11.89 | -23.27 | 90.61 | 83.95 | Upgrade
|
| Other Operating Activities | 204.82 | 86.71 | 199.37 | 129.61 | 96.86 | Upgrade
|
| Change in Accounts Receivable | 398.16 | 940.33 | 984.81 | -1,778 | -1,707 | Upgrade
|
| Change in Inventory | -40.54 | -58.18 | -218.34 | -296.47 | -222.97 | Upgrade
|
| Change in Accounts Payable | -183.4 | -805.75 | -935.62 | 1,116 | 1,322 | Upgrade
|
| Change in Other Net Operating Assets | -14.15 | -5.28 | - | - | -0 | Upgrade
|
| Operating Cash Flow | 89.75 | 355.08 | 1,538 | 4,133 | 1,682 | Upgrade
|
| Operating Cash Flow Growth | -74.72% | -76.91% | -62.79% | 145.70% | 259.23% | Upgrade
|
| Capital Expenditures | -805.16 | -887.35 | -1,160 | -929.91 | -1,048 | Upgrade
|
| Sale of Property, Plant & Equipment | 210.73 | 16.06 | 0.72 | 0.89 | 8.19 | Upgrade
|
| Cash Acquisitions | - | - | -0.71 | - | - | Upgrade
|
| Investment in Securities | -281.81 | -794.66 | -960.3 | -2,589 | 14.39 | Upgrade
|
| Other Investing Activities | 117.24 | 162.59 | 66.23 | 3.9 | 11.11 | Upgrade
|
| Investing Cash Flow | -759.01 | -1,503 | -2,054 | -3,514 | -1,014 | Upgrade
|
| Long-Term Debt Issued | 343.56 | 231.24 | 186.44 | 351.6 | 240.35 | Upgrade
|
| Long-Term Debt Repaid | -339.89 | -272.81 | -170.57 | -352.46 | -92.06 | Upgrade
|
| Net Debt Issued (Repaid) | 3.67 | -41.57 | 15.87 | -0.86 | 148.29 | Upgrade
|
| Issuance of Common Stock | - | 78.21 | 54 | 3,461 | 10 | Upgrade
|
| Repurchase of Common Stock | - | -238.44 | -15.65 | -200.17 | - | Upgrade
|
| Common Dividends Paid | -2.28 | -410.94 | -907.47 | -127.49 | -112.74 | Upgrade
|
| Other Financing Activities | -0.92 | - | -40 | -5.68 | 7.23 | Upgrade
|
| Financing Cash Flow | 0.47 | -612.74 | -893.26 | 3,127 | 52.79 | Upgrade
|
| Foreign Exchange Rate Adjustments | -13.27 | 4.38 | 7.62 | 26.26 | -8.75 | Upgrade
|
| Net Cash Flow | -682.05 | -1,757 | -1,402 | 3,772 | 711.88 | Upgrade
|
| Free Cash Flow | -715.41 | -532.27 | 378.15 | 3,203 | 634.16 | Upgrade
|
| Free Cash Flow Growth | - | - | -88.19% | 405.03% | 715.43% | Upgrade
|
| Free Cash Flow Margin | -39.33% | -23.71% | 6.86% | 28.63% | 11.03% | Upgrade
|
| Free Cash Flow Per Share | -0.56 | -0.40 | 0.30 | 2.56 | 0.52 | Upgrade
|
| Cash Income Tax Paid | 163.2 | 114.16 | 537.3 | 1,164 | 295.76 | Upgrade
|
| Levered Free Cash Flow | -589.82 | -22.12 | -308.83 | 1,738 | -4.04 | Upgrade
|
| Unlevered Free Cash Flow | -585.78 | -16.92 | -304.55 | 1,743 | -0.48 | Upgrade
|
| Change in Working Capital | 65.23 | -14.26 | -278.25 | -938.6 | -620.35 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.